Please login to the form below

Not currently logged in
Email:
Password:

Wilson's disease

This page shows the latest Wilson's disease news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy. Also acquires the Swedish group’s lead product for Wilson’s disease. ... Sweden-based Wilson’s lead product is WTX101, currently in phase III development for the genetic disorder Wilson’s

Latest news

  • Archive listing

    Also acquires the Swedish group’s lead product for Wilson’s disease. . ... Interim data suggested there was no improvement on disease-free survival compared to placebo. .

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics